MRX-5

N/A

Report date: 2026/02/02 09:12:32
NME

Base Information

Drug NameMRX-5
Drug Alias NameMRX-5MRX-6038MRX-V
ClassificationSmall molecules > Heterocyclic drugs > Antibiotics
Mechanisms of ActionLeucyl-tRNA synthetase inhibitors
TargetsLeucyl-tRNA synthetase
Therapy Area/IndicationsLung DiseasesMycobacterium Infections, NontuberculousMycobacterium Infections +[5
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesAustraliaMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 1 Clinical
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Inactive CompaniesN/A
Active IndicationsLung DiseasesMycobacterium Infections, NontuberculousMycobacterium Infections +[5
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A